{"id":12668,"date":"2024-10-11T17:43:16","date_gmt":"2024-10-11T15:43:16","guid":{"rendered":"https:\/\/valintermed.com\/?p=12668"},"modified":"2024-10-11T17:43:16","modified_gmt":"2024-10-11T15:43:16","slug":"sindrom-park","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-park\/","title":{"rendered":"PARK syndrome"},"content":{"rendered":"
<\/div>\n

PARK syndrome (or Parkinsonism syndrome with dopamine deficiency) is a group of neurodegenerative diseases that manifest symptoms similar to Parkinson's disease, but differ in etiology, pathogenesis and clinical features. The main characteristics of PARK syndrome include progressive impairment of motor function, including temporary slowness of movement (bradykinesia), muscle rigidity and tremor. Pathological changes observed in this syndrome may be associated with the peculiarities of the mechanism of interaction of neurotransmitters in the brain, as well as with the addition of various intracranial changes and oxidative stress activity. Given the complex etiology, various genetic and acquired factors are attributed to this group of syndromes, emphasizing the importance of taking them into account when developing diagnostic and therapeutic methods.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n